Hypersensitivity Pneumonitis Market Outlook:
Hypersensitivity Pneumonitis Market size was over USD 1.51 billion in 2025 and is anticipated to cross USD 2.55 billion by 2035, growing at more than 5.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of hypersensitivity pneumonitis is assessed at USD 1.58 billion.
The reason behind the growth is impelled by the increasing prevalence of respiratory diseases across the globe. The third biggest cause of mortality is chronic respiratory conditions caused by risk factors including allergens, occupational dangers, and tobacco use. This has increased awareness regarding such conditions among people, leading to better treatment options for hypersensitivity pneumonitis as well. Each year, asthma accounts for more than 160 000 fatalities worldwide.
The development of non-invasive diagnostic procedures are believed to fuel the hypersensitivity pneumonitis market. Imaging and spirometry are non-invasive techniques used in diagnosis and the measurement of the lung's capacity to inhale and exhale air. For instance, HRCT is a noninvasive, precise diagnostic technology used for the proper diagnosis of chronic hypersensitivity pneumonitis.
